Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Cluster Randomised Trial of the Safety of Co-Administration of IDA (Ivermectin, Diethylcarbamazine and Albendazole) & Azithromycin for Integrated Treatment of Neglected Tropical Diseases

NCT03676140 is registered in ClinicalTrials.gov with Lihir Medical Centre as lead sponsor.

NCT NCT03676140
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03676140 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Cluster Randomised Trial of the Safety of Co-Administration of IDA (Ivermectin, Diethylcarbamazine and Albendazole) & Azithromycin for Integrated Treatment of Neglected Tropical Diseases
Lead sponsor
Lihir Medical Centre
Phase
Phase 3
Overall status
Completed
Start date
October 1, 2018
Completion date
January 1, 2019
Enrollment
20,000 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lymphatic filariases, scabies, strongyloidiasis, trachoma, yaws